Liisa Ann Bayko
Chief Financial Officer · Kalaris Therapeutics, Inc.
Individual
- 2026
- Jul 20, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Liisa Ann Bayko files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Srinivas Akkaraju - $6.18M in KLRS purchases and sales in the last 12 months
- Brett R. Hagen - $13K in KLRS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Liisa Ann Bayko?
Liisa Ann Bayko is a corporate insider, tracked as Chief Financial Officer of Kalaris Therapeutics, Inc. (KLRS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Liisa Ann Bayko submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.